Connection
Naghmehossadat Eshghi to Carcinoma, Merkel Cell
This is a "connection" page, showing publications Naghmehossadat Eshghi has written about Carcinoma, Merkel Cell.
|
|
Connection Strength |
|
|
|
|
|
0.601 |
|
|
|
-
Eshghi N, Lundeen TF, MacKinnon L, Avery R, Kuo PH. 18F-FDG PET/CT for Monitoring Response of Merkel Cell Carcinoma to the Novel Programmed Cell Death Ligand 1 Inhibitor Avelumab. Clin Nucl Med. 2018 May; 43(5):e142-e144.
Score: 0.601